Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Primary Myelofibrosis 8Myelodysplastic Syndromes 8Leukemia 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Multiple Myeloma 7Lymphoma 7Myeloproliferative Disorders 6Lymphoma, Non-Hodgkin 6Hodgkin Disease 6Blast Crisis 6Polycythemia Vera 5Lymphoma, Mantle-Cell 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myeloid, Chronic-Phase 5Leukemia, Myeloid, Accelerated Phase 5Burkitt Lymphoma 5Thrombocythemia, Essential 4Neoplasms, Plasma Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Acute 4Leukemia, Lymphocytic, Chronic, B-Cell 4Congenital Abnormalities 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Graft vs Host Disease 3Testicular Neoplasms 2Sezary Syndrome 2Recurrence 2

Interventions

ruxolitinib 4Specimen Handling 3Biopsy 3venetoclax 2trametinib 1sonidegib 1siltuximab 1regorafenib 1ponatinib 1pomalidomide 1pevonedistat 1pertuzumab 1pembrolizumab 1pelcitoclax 1peginterferon alfa-2b 1palbociclib 1olaparib 1neratinib 1luspatercept 1lorlatinib 1lenvatinib 1itacitinib 1imetelstat 1idelalisib 1enzalutamide 1entrectinib 1enasidenib 1durvalumab 1dehydroftorafur 1darolutamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thrombocytosis × Prednisone × Myeloid × Clear all
NCT00946270 2019-06-10

Pomalidomide for Myelofibrosis Patients

M.D. Anderson Cancer Center

Phase 2 Completed
70 enrolled 10 charts
Myeloid

Polycythemia Vera, Thrombocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡